Balancing the good and the bad: controlling immune-related adverse events versus anti-tumor responses in cancer patients treated with immune checkpoint inhibitors
Author(s) -
Guilherme Ferreira de Britto Evangelista,
Amanda Braga Figueiredo,
Milton Barros,
Kenneth J. Gollob
Publication year - 2022
Publication title -
immunotherapy advances
Language(s) - English
Resource type - Journals
ISSN - 2732-4303
DOI - 10.1093/immadv/ltac008
Subject(s) - medicine , immune checkpoint , immune system , microsatellite instability , immunotherapy , melanoma , cancer , adverse effect , tumor microenvironment , ipilimumab , oncology , cancer immunotherapy , nivolumab , immunology , cancer research , biology , allele , biochemistry , microsatellite , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom